Sanat Chattopadhyay
Net Worth

Last updated:

What is Sanat Chattopadhyay net worth?

The estimated net worth of Mr. Sanat Chattopadhyay is at least $56,852,265 as of 13 Apr 2023. He owns shares worth $5,766,068 as insider, has earned $37,046,197 from insider trading and has received compensation worth at least $14,040,000 in Merck & Co., Inc..

What is the salary of Sanat Chattopadhyay?

Mr. Sanat Chattopadhyay salary is $1,560,000 per year as Executive Vice President & Pres of Merck Manufacturing Division in Merck & Co., Inc..

How old is Sanat Chattopadhyay?

Mr. Sanat Chattopadhyay is 65 years old, born in 1960.

What stocks does Sanat Chattopadhyay currently own?

As insider, Mr. Sanat Chattopadhyay owns shares in one company:

Company Title Shares Price per share Total value
Merck & Co., Inc. (MRK) Executive Vice President & Pres of Merck Manufacturing Division 67,892 $84.93 $5,766,068

What does Merck & Co., Inc. do?

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

MRK logo
MRK
Merck & Co., Inc.
$84.93

Sanat Chattopadhyay insider trading

Merck & Co., Inc.

Mr. Sanat Chattopadhyay has made 12 insider trades between 2016-2023, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 134,055 units of MRK stock on 13 Apr 2023. As of 13 Apr 2023 he still owns at least 67,892 units of MRK stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 66,163 $62.07 $4,106,737
Sale
Common Stock 66,163 $115.06 $7,612,715
Option
Stock Option (Right to Buy) 134,055 $59.06 $7,916,618
Sale
Common Stock 67,892 $115.07 $7,812,400
Option
Common Stock 67,892 $56.04 $3,804,668
Option
Stock Option (Right to Buy) 83,994 $53.06 $4,456,722
Option
Common Stock 83,994 $53.06 $4,456,722
Sale
Common Stock 4,538 $111.73 $507,049
Sale
Common Stock 3,940 $112.78 $444,361
Sale
Common Stock 35,598 $110.62 $3,937,673
Sale
Common Stock 38,216 $113.78 $4,348,025
Sale
Common Stock 1,702 $114.46 $194,813
Option
Common Stock 51,055 N/A N/A
Option
Stock Option (Right to Buy) 51,055 $58.08 $2,965,274
Option
Common Stock 15,213 N/A N/A
Option
Common Stock 34,024 N/A N/A
Sale
Common Stock 100,292 $100.1 $10,039,430
Sale
Common Stock 24,619 $87.32 $2,149,731
Option
Stock Option (Right to Buy) 24,619 $43.65 $1,074,619
Option
Common Stock 24,619 N/A N/A
Sale
Common Stock 10,380 N/A N/A
Sale
Common Stock 73,727 N/A N/A
Option
Stock Option (right to buy) 43,876 N/A N/A
Option
Common Stock 73,727 N/A N/A
Sale
Common Stock 29,208 N/A N/A
Option
Common Stock 29,208 N/A N/A
Option
Stock Option (right to buy) 10,000 N/A N/A
Option
Common Stock 4,009 N/A N/A
Option
Restricted Stock Unit 4,009 N/A N/A
Option
Common Stock 3,092 N/A N/A
Option
Restricted Stock Unit 3,092 N/A N/A
Option
Restricted Stock Unit 5,150 N/A N/A
Option
Common Stock 5,150 N/A N/A
Option
Common Stock 4,002 N/A N/A
Option
Restricted Stock Unit 4,002 N/A N/A

Merck & Co. key executives

Merck & Co., Inc. executives and other stock owners filed with the SEC: